CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Millennium Pharmaceuticals Inc. v. Hospira, Inc.

1:15-cv-00804

Overview

Case Number 1:15-cv-00804
Filing Date 2015-09-10
Status Terminated
Termination Date 2018-03-26
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Hospira, Inc. Operating Company

Represented By

4 Attorneys Listed

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Thomas J. Meloro

Email: tmeloro@willkie.com

Sara O'Brien

UNDELIVERABLE EMAIL 1/25/2016

Michael W. Johnson

Email: mjohnson1@willkie.com

Plaintiff

Millennium Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 9 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (9 found):
U.S. Courts: 9
U.S. District Court 2017-04-13
1:17-cv-00423

Millennium Pharmaceuticals, Inc. v. Zydus Pharmaceuticals (USA) Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-04-13
1:17-cv-00422

Millennium Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC

Asserted Patent
Status: DED
U.S. District Court 2016-04-04
1:16-cv-00223

Millennium Pharmaceuticals Inc. v. Actavis LLC

Asserted Patent
Status: DED
U.S. District Court 2015-06-25
1:15-cv-00540

Millennium Pharmaceuticals Inc. v. Sun Pharmaceutical Industries Limited

Asserted Patent
Status: DED
U.S. District Court 2015-01-14
1:15-cv-00039

Millennium Pharmaceuticals Inc. v. Hetero Labs Limited

Asserted Patent
Status: DED
U.S. District Court 2015-01-14
1:15-cv-00040

Millennium Pharmaceuticals Inc. v. Mylan Laboratories Limited

Asserted Patent
Status: DED
U.S. District Court 2014-01-22
1:14-cv-00093

Millennium Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-03-22
1:13-cv-00467

Millennium Pharmaceuticals Inc. v. Fresenius Kabi USA LLC

Asserted Patent
Status: DED
U.S. District Court 2012-12-21
1:12-cv-01750

Millennium Pharmaceuticals Inc. v. Actavis Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6713446
Formulation of boronic acid compounds
Filed: 2002-01-25
Issued: 2004-03-30
Expired (Term Ended)
Expires: 2022-01-25
US6958319
Formulation of boronic acid compounds
Filed: 2003-09-18
Issued: 2005-10-25
Expired (Term Ended)
Expires: 2022-04-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 4

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED - re 14 STIPULATION TO EXTEND TIME for parties to file a Joint Status Report to December 3, 2015. Ordered by Judge Gregory M. Sleet on 11/23/2015. (m...
Entry #β€” • 2015-11-23
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for parties to file a Joint Status Report to December 3, 2015 - filed by Millennium Pharmaceuticals Inc.. (Noreika, Maryellen) (Enter...
Entry #14 • 2015-11-19 Document →
Procedural / Extension Motion Pending
SO ORDERED - re 13 STIPULATION TO EXTEND TIME for the parties to file their joint status report to November 19, 2015 filed by Millennium Pharmaceuticals Inc. Or...
Entry #β€” • 2015-11-09
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to file their joint status report to November 19, 2015 - filed by Millennium Pharmaceuticals Inc.. (Noreika, Maryelle...
Entry #13 • 2015-11-05 Document →

Docket Entries

(46 total)
Pleading / Complaint

COMPLAINT filed against Hospira, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1785139.) - filed by Millennium Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A & B, # 2 Civil Cover Sheet)(nmb) (Entered: 09/10/2015)

Entry #1 • 2015-09-10
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 09/10/2015)

Entry #2 • 2015-09-10
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/28/2015. Date of Expiration of Patent: 1/25/2022.Thirty Month Stay Deadline: 1/28/2018. (nmb) (Entered: 09/10/2015)

Entry #3 • 2015-09-10
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,713,446 B2; 6,958,319 B2;. (nmb) (Entered: 09/10/2015)

Entry #4 • 2015-09-10
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceuticals Company Limited for Millennium Pharmaceuticals Inc. filed by Millennium Pharmaceuticals Inc.. (nmb) (Entered: 09/10/2015)

Entry #5 • 2015-09-10
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc